Literature DB >> 18372180

An epoxidation mechanism of carbamazepine by CYP3A4.

Masayuki Hata1, Yoshikazu Tanaka, Naoko Kyoda, Taisuke Osakabe, Hitomi Yuki, Itsuko Ishii, Mitsukazu Kitada, Saburo Neya, Tyuji Hoshino.   

Abstract

Human CYP3A4 catalyzes the 10,11-epoxidation of carbamazepine (CBZ). However, the epoxide is less stable in terms of potential energy than hydroxides of the six-membered aromatic ring. To clarify the reason why CYP3A4 produces such an energetically unfavorable compound, the mechanism of epoxidation of CBZ by CYP3A4 was investigated by theoretical calculations. The reaction consisted of two elementary processes in which two C-O bonds were generated stepwise. The rate-determining step was the first one and the activation energy was 21.3kcal/mol at the DFT (B3LYP/6-31G( * *)) level. The activation energy level of the first step of the 10,11-epoxidation was lower than that of the hydroxylation of the aromatic ring. For this reason, 10,11-epoxidation is more probable than hydroxylation of the aromatic ring, and only 10,11-epoxide is formed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372180     DOI: 10.1016/j.bmc.2008.03.023

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  1 in total

1.  Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.

Authors:  S E Marino; A K Birnbaum; I E Leppik; J M Conway; L C Musib; R C Brundage; R E Ramsay; P B Pennell; J R White; C R Gross; J O Rarick; U Mishra; J C Cloyd
Journal:  Clin Pharmacol Ther       Date:  2012-01-25       Impact factor: 6.875

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.